

United by passion and purpose: How two colleagues are fighting against MS
Imagine being at the forefront of cutting-edge medical research, working tirelessly to find cures for debilitating diseases like multiple sclerosis (MS) – and then being diagnosed with it yourself. Or being so passionate about eradicating MS that you dedicate your free time to fundraising – only to discover that two of your own family members are now battling the disease you’ve been fighting to cure.
This is the reality for John Hamlet, Leader of Clinical Delivery for MS, and Scott Savett, Senior Software Analyst. Their personal connections with the disease have transformed their professional journeys into deeply personal crusades for hope and healing.
Thermo Fisher is making a profound impact on patients' lives by enabling our customers to accelerate MS research, diagnosis and treatment. “From unlocking vital proteomic and metabolic insights to advancing precision diagnostics for faster detection and supporting promising clinical trials, we're bringing hope and better outcomes to those affected by this challenging disease,” said John.
John and Scott’s paths converged serendipitously at an Hola! Business Resource Group, a networking organization for colleagues of Hispanic Heritage, event, where John met a mutual colleague who recognized their shared dedication and suggested he and Scott connect. This chance meeting revealed a common purpose, sparking a powerful partnership.
Though they are about 1,500 miles apart, with Scott in Maryland and John in Texas, the two connect regularly and have become invaluable allies, creating community, amplifying each other’s efforts and inspiring greater involvement in MS-related initiatives across the company. Their collaboration has not only strengthened their advocacy but also enabled them to share their stories and encourage others to join the cause.
While Scott may look the part of a serious cyclist in his cycling shoes, padded shorts and Thermo Fisher Scientific jersey, he’s actually a casual cyclist with a modest road bike. He says that cycling is a mere mechanism to bring people together to support the MS Society.
John Hamlet stands at the intersection of science and empathy. By a twist of fate, John was already working on MS clinical trials when he was diagnosed with the disease himself, which has made his journey uniquely profound.
John’s experience with the disease positions him to drive advancements in new therapies, including a medication he personally uses and developed by Thermo Fisher.
One of the most rewarding aspects of John’s journey is his ability to connect with newly diagnosed patients. By sharing his own experiences, he offers hope, guidance and reassurance to those navigating similar challenges.
To maximize his impact, John speaks at team meetings, participates in podcasts and actively engages with local patient advocacy groups – ensuring his message reaches and uplifts as many people as possible.
"The outpouring of support from my co-workers is amazing. When people started seeking me out with their own diagnosis, I realized that my experience as a patient and my experience as a researcher gave me a unique perspective that allowed me to help them navigate their own experiences with hope and peace."
Looking ahead, John envisions Thermo Fisher remaining at the forefront of MS research and treatment, with the ultimate goal of ending the debilitating disease. "I have an amazing privilege to sit in the chair of leading the clinical development for MS at a time when amazing new therapies are in development. Thermo Fisher can lead the work to bring an end to MS. This is real. This is close."